Met Life Investment Management, LLC Biomarin Pharmaceutical Inc Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 107,403 shares of BMRN stock, worth $6.97 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
107,403
Previous 98,372 9.18%
Holding current value
$6.97 Million
Previous $6.91 Million 2.1%
% of portfolio
0.04%
Previous 0.04%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$61.93 - $70.49 $559,289 - $636,595
9,031 Added 9.18%
107,403 $7.06 Million
Q3 2024

Nov 13, 2024
SELL
$69.02 - $93.84 $110,224 - $149,862
-1,597 Reduced 1.6%
98,372 $6.91 Million
Q2 2024

Aug 13, 2024
BUY
$74.43 - $92.22 $7.1 Million - $8.8 Million
95,406 Added 2090.86%
99,969 $8.23 Million
Q1 2024

May 14, 2024
BUY
$83.81 - $99.0 $382,425 - $451,737
4,563 New
4,563 $398,000
Q4 2023

Feb 14, 2024
SELL
$76.22 - $98.51 $6,097 - $7,880
-80 Reduced 1.73%
4,551 $438,000
Q3 2023

May 09, 2024
BUY
$85.07 - $94.48 $68,821 - $76,434
809 Added 21.17%
4,631 $409,000
Q3 2023

Apr 29, 2024
BUY
$85.07 - $94.48 $510 - $566
6 Added 0.13%
4,631 $409,000
Q3 2023

Nov 14, 2023
BUY
$85.07 - $94.48 $510 - $566
6 Added 0.13%
4,631 $409,000
Q2 2023

Apr 29, 2024
BUY
$86.68 - $100.3 $400,895 - $463,887
4,625 New
4,625 $400,000
Q2 2023

Aug 10, 2023
BUY
$86.68 - $100.3 $69,604 - $80,540
803 Added 21.01%
4,625 $400,000
Q1 2023

May 09, 2024
BUY
$87.74 - $117.27 $335,342 - $448,205
3,822 New
3,822 $372 Million
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $701 - $938
8 Added 0.21%
3,822 $371,000
Q4 2022

May 10, 2024
BUY
$80.93 - $108.63 $1,456 - $1,955
18 Added 0.47%
3,814 $394,000
Q4 2022

Jun 14, 2023
SELL
$80.93 - $108.63 $647 - $869
-8 Reduced 0.21%
3,814 $394,000
Q4 2022

Mar 22, 2023
BUY
$80.93 - $108.63 $1,456 - $1,955
18 Added 0.47%
3,814 $394,000
Q4 2022

Feb 15, 2023
BUY
$80.93 - $108.63 $1,456 - $1,955
18 Added 0.47%
3,814 $394,000
Q3 2022

May 10, 2024
SELL
$82.16 - $96.94 $7,558 - $8,918
-92 Reduced 2.37%
3,796 $321,000
Q3 2022

Jun 14, 2023
SELL
$82.16 - $96.94 $2,136 - $2,520
-26 Reduced 0.68%
3,796 $321,000
Q3 2022

Mar 22, 2023
SELL
$82.16 - $96.94 $7,558 - $8,918
-92 Reduced 2.37%
3,796 $321,000
Q3 2022

Nov 14, 2022
SELL
$82.16 - $96.94 $7,558 - $8,918
-92 Reduced 2.37%
3,796 $322,000
Q2 2022

May 10, 2024
BUY
$71.48 - $86.85 $17,226 - $20,930
241 Added 6.61%
3,888 $322,000
Q2 2022

Jun 20, 2023
BUY
$71.48 - $86.85 $4,717 - $5,732
66 Added 1.73%
3,888 $322,000
Q2 2022

Mar 22, 2023
BUY
$71.48 - $86.85 $17,226 - $20,930
241 Added 6.61%
3,888 $322,000
Q2 2022

Aug 11, 2022
BUY
$71.48 - $86.85 $17,226 - $20,930
241 Added 6.61%
3,888 $322,000
Q1 2022

May 10, 2024
BUY
$74.28 - $92.69 $270,899 - $338,040
3,647 New
3,647 $281,000
Q1 2022

Jun 20, 2023
SELL
$74.28 - $92.69 $12,999 - $16,220
-175 Reduced 4.58%
3,647 $281,000
Q1 2022

Mar 22, 2023
BUY
$74.28 - $92.69 $1,411 - $1,761
19 Added 0.52%
3,647 $281,000
Q1 2022

May 12, 2022
BUY
$74.28 - $92.69 $270,899 - $338,040
3,647 New
3,647 $281,000
Q4 2021

Feb 15, 2022
SELL
$71.72 - $91.47 $260,200 - $331,853
-3,628 Closed
0 $0
Q3 2021

Mar 22, 2023
BUY
$74.77 - $85.47 $245,843 - $281,025
3,288 Added 967.06%
3,628 $280,000
Q3 2021

Nov 15, 2021
BUY
$74.77 - $85.47 $271,265 - $310,085
3,628 New
3,628 $280,000
Q2 2021

Aug 16, 2021
SELL
$75.51 - $84.79 $25,673 - $28,828
-340 Closed
0 $0
Q1 2021

Mar 22, 2023
BUY
$74.73 - $90.69 $7,323 - $8,887
98 Added 40.5%
340 $25,000
Q1 2021

May 14, 2021
BUY
$74.73 - $90.69 $25,408 - $30,834
340 New
340 $26,000
Q2 2019

Aug 14, 2019
SELL
$80.35 - $93.9 $19,444 - $22,723
-242 Closed
0 $0
Q1 2019

Jul 13, 2023
SELL
$84.2 - $98.62 $301,436 - $353,059
-3,580 Reduced 93.67%
242 $21,000
Q1 2019

Mar 22, 2023
BUY
$84.2 - $98.62 $84 - $98
1 Added 0.41%
242 $21,000
Q1 2019

May 15, 2019
BUY
$84.2 - $98.62 $84 - $98
1 Added 0.41%
242 $21,000
Q4 2018

Jul 13, 2023
SELL
$80.14 - $106.07 $286,981 - $379,836
-3,581 Reduced 93.69%
241 $20,000
Q4 2018

Mar 22, 2023
SELL
$80.14 - $106.07 $160 - $212
-2 Reduced 0.82%
241 $20,000
Q4 2018

Feb 14, 2019
SELL
$80.14 - $106.07 $160 - $212
-2 Reduced 0.82%
241 $21,000
Q3 2018

Jul 13, 2023
SELL
$93.92 - $105.72 $336,139 - $378,371
-3,579 Reduced 93.64%
243 $23,000
Q3 2018

Mar 22, 2023
SELL
$93.92 - $105.72 $335,388 - $377,526
-3,571 Reduced 93.63%
243 $23,000
Q3 2018

Nov 14, 2018
BUY
$93.92 - $105.72 $22,822 - $25,689
243 New
243 $24,000

Others Institutions Holding BMRN

# of Institutions
626
Shares Held
183M
Call Options Held
2M
Put Options Held
1.67M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email